111 – 120 of 343
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Podocalyxin-like and rna-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer : A validatory study
(
- Contribution to journal › Article
- 2016
-
Mark
The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.
(
- Contribution to journal › Article
-
Mark
Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article
-
Mark
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
(
- Contribution to journal › Article